Health Plans Want RICO Case against Abbott Labs Reinstated
September 14, 2017
Several health plans have requested that the Seventh Circuit Court reinstate their proposed Racketeer Influenced and Corrupt Organizations (RICO) Act class action suit against Abbott Labs over its alleged promotion of its antiseizure medication Depakote for off-label uses.
Plaintiffs in the case include the Sidney Hillman Health Center of Rochester, N.Y., the Teamsters Health Services, and Insurance Plan Local 404. They argue that such benefits plans as themselves are among the victims when drug companies encourage doctors to prescribe drugs for uses that are not recommended by the U.S. Food and Drug Administration (FDA), as plans’ funds are disbursed under false pretenses.
In 2012, Abbott entered into a $1.2 billion settlement to resolve a criminal investigation and civil claims concerning the alleged marketing of Depakote for unapproved uses.
Depakote is used to treat seizure and bipolar disorders. Plaintiffs allege that Abbott pressured doctors to recommend the drug for other conditions for which cheaper and more effective drugs would have been more appropriate.
The complex case is ongoing in Illinois federal court.
If you’ve been inappropriately prescribed Depakote, and it has endangered your health, you may be entitled to file a lawsuit against Abbott Labs. If and when you do, the expert attorneys at TheLawFirm.com are standing by to help you with your case.
Bad Drug Depakote
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!